Terns Pharmaceuticals, Inc.
TERN
Rangering i aksjer
#3573
Terns Pharmaceuticals, Inc. is a biopharmaceutical firm currently in the... Terns Pharmaceuticals, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to advancing novel small-molecule treatments. Its primary focus lies in developing both standalone agents and combination therapies to address non-alcoholic steatohepatitis (NASH) and obesity. The company's pipeline includes several key drug candidates: TERN-101, a farnesoid X receptor agonist distinguished by its liver-specific distribution and non-bile acid properties, is presently undergoing Phase IIa clinical trials for NASH. TERN-201, a vascular adhesion protein-1 inhibitor, is in Phase Ib clinical studies, also targeting NASH. Terns is also progressing TERN-501, a thyroid hormone receptor beta agonist engineered for improved liver targeting and metabolic resilience, through Phase I clinical trials for NASH. Furthermore, the company is advancing TERN-601, an oral small-molecule Glucagon-Like Peptide-1 receptor agonist program, intended for the management of NASH and various metabolic conditions, including obesity. Established in 2016, Terns Pharmaceuticals maintains its corporate headquarters in Foster City, California.
Aksjekurs
$52.95
Sist synkronisert: 2026-05-15
Markedsverdi
$4.77B
Endring (1 dag)
0.00%
Endring (1 år)
514.27%
Land
US
Handel Terns Pharmaceuticals, Inc. (TERN)
Kategori
Healthcare
Historikk for aksjesplitt for Terns Pharmaceuticals, Inc. (TERN)
Aksjen Terns Pharmaceuticals, Inc. (symbol: TERN) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 20, 2026.
Én TERN-aksje kjøpt før Oct 20, 2026 tilsvarer i dag 0 TERN-aksjer.
Den nyeste splittelsen skjedde Oct 20, 2026.
Én TERN-aksje kjøpt før Oct 20, 2026 tilsvarer i dag 0 TERN-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
